Mamman M, Gettinby G, Murphy N B, Kemei S, Peregrine A S
International Laboratory for Research on Animal Diseases, Nairobi, Kenya.
Antimicrob Agents Chemother. 1995 May;39(5):1107-13. doi: 10.1128/AAC.39.5.1107.
The frequency of trypanosomes resistant to diminazene aceturate at a dose of 25 mg/kg of body weight was investigated for populations of Trypanosoma congolense IL 3274 which reappeared in infected mice after intraperitoneal treatment with diminazene aceturate at the same dosage. At inoculum sizes of 10(2), 10(3), 10(4), 10(5), and 10(6) trypanosomes per mouse, the relapse populations were used to initiate infections in five groups of 100 mice each by the intravenous route. Immediately after infection, 50 mice in each group were treated intraperitoneally with diminazene aceturate at the aforementioned dosage; the other 50 mice functioned as untreated controls. Thereafter, all animals were monitored for 100 days for the presence of trypanosomes. In each group, trypanosomes were detected in 50 of 50 control mice, indicating 100% infectivity for all five inoculum sizes. In contrast, in the groups of 50 mice infected with 10(2), 10(3), 10(4), 10(5) and 10(6) trypanosomes and treated with diminazene aceturate, trypanosomes were detected in 4, 11, 13, 28, and 39 of 50 mice, respectively. By logistic regression, a good fit was found between the number of mice identified as parasitemic and the inoculum sizes. Maximum likelihood estimates for the proportions of trypanosomes resistant to diminazene aceturate at 25 mg/kg of body weight for the inoculum of 10(2), 10(3), 10(4), 10(5), and 10(6) organisms were 8.335 x 10(-4), 2.485 x 10(-4), 3.02 x 10(-5), 8.3 x 10(-6), and 1.6 x 10(-6), respectively. These finding indicate that the majority of the relapse trypanosomes were susceptible the the drug dosage used for selecting the population and that, surprisingly, the calculated proportion of organisms which survived drug exposure varied inversely with the inoculum size. Further experiments with mice indicated that the inverse relationship did not result from alterations in the pharmacokinetics of the drug with different inoculum sizes. The data therefore suggest that parasite inoculum size and drug dosage are important factors in estimating the apparent frequency of diminazene-resistant trypanosomes in populations of T. congolense occurring in vivo.
对刚果锥虫IL 3274群体进行研究,以调查在体重25mg/kg剂量下对乙酰氨基阿苯达唑耐药的锥虫频率。该群体是在用相同剂量的乙酰氨基阿苯达唑腹腔注射处理感染小鼠后再次出现的。以每只小鼠接种10²、10³、10⁴、10⁵和10⁶个锥虫的接种量,将复发群体通过静脉途径用于每组100只小鼠的感染起始。感染后立即,每组50只小鼠用上述剂量的乙酰氨基阿苯达唑腹腔注射处理;另外50只小鼠作为未处理对照。此后,对所有动物监测100天以检测锥虫的存在。在每组中,50只对照小鼠中有50只检测到锥虫,表明所有五种接种量的感染率均为100%。相比之下,在感染10²、10³、10⁴、10⁵和10⁶个锥虫并接受乙酰氨基阿苯达唑处理的50只小鼠组中,50只小鼠中分别有4只、11只、13只、28只和39只检测到锥虫。通过逻辑回归,发现被鉴定为有寄生虫血症的小鼠数量与接种量之间拟合良好。对于接种量为10²、10³、10⁴、10⁵和10⁶个生物体的群体,在体重25mg/kg剂量下对乙酰氨基阿苯达唑耐药的锥虫比例的最大似然估计分别为8.335×10⁻⁴、2.485×10⁻⁴、3.02×10⁻⁵、8.3×10⁻⁶和1.6×10⁻⁶。这些发现表明,大多数复发锥虫对用于选择群体的药物剂量敏感,并且令人惊讶的是,经药物暴露后存活的生物体计算比例与接种量成反比。对小鼠的进一步实验表明,这种反比关系不是由不同接种量下药物的药代动力学改变引起的。因此,数据表明寄生虫接种量和药物剂量是估计体内刚果锥虫群体中乙酰氨基阿苯达唑耐药锥虫表观频率的重要因素。